In an effort to define and explore the diminishing benefits of anti-VEGF therapy, we have considered multiple key definitions from the existing literature, employing a composite definition that includes both functional and anatomical parameters to capture vision loss due to persistence of oedema, and by inference absence of response to anti-VEGF. This evidence concerns the gene VEGFA and edema.